Showing results (101-110 of 115) with videos related to
Sort By:
Pageof 12
Nature|March 5, 2014
Developmental pathway for potent V1V2-directed HIV-neutralizing antibodiesNicole A Doria-Rose, Chaim A Schramm, Jason Gorman, et al.Biorxiv : the Preprint Server for Biology|April 5, 2022
Primary exposure to SARS-CoV-2 variants elicits convergent epitope specificities, immunoglobulin V gene usage and public B cell clonesNoemia S Lima, Maryam Musayev, Timothy S Johnston, et al.Cell|May 26, 2015
Structural Repertoire of HIV-1-Neutralizing Antibodies Targeting the CD4 Supersite in 14 DonorsTongqing Zhou, Rebecca M Lynch, Lei Chen, et al.Nature Communications|December 14, 2022
Primary exposure to SARS-CoV-2 variants elicits convergent epitope specificities, immunoglobulin V gene usage and public B cell clonesNoemia S Lima, Maryam Musayev, Timothy S Johnston, et al.Biorxiv : the Preprint Server for Biology|August 24, 2021
Protection against SARS-CoV-2 Beta Variant in mRNA-1273 Boosted Nonhuman PrimatesKizzmekia S Corbett, Matthew Gagne, Danielle A Wagner, et al.Biorxiv : the Preprint Server for Biology|June 25, 2020
SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen PreparednessKizzmekia S Corbett, Darin Edwards, Sarah R Leist, et al.Science (New York, N.Y.)|July 2, 2021
Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variantsLingshu Wang, Tongqing Zhou, Yi Zhang, et al.Nature|August 7, 2020
SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparednessKizzmekia S Corbett, Darin K Edwards, Sarah R Leist, et al.Science (New York, N.Y.)|October 21, 2021
Protection against SARS-CoV-2 Beta variant in mRNA-1273 vaccine-boosted nonhuman primatesKizzmekia S Corbett, Matthew Gagne, Danielle A Wagner, et al.Cell|October 29, 2024
Potent and broad HIV-1 neutralization in fusion peptide-primed SHIV-infected macaquesHua Wang, Cheng Cheng, James L Dal Santo, et al.Pageof 12